Ultramarine & Pigments Ltd. Overview
| Field | Detail |
|---|---|
| Legal name | Ultramarine & Pigments Limited |
| Former names | None identified in available records |
| Founding / incorporation | Incorporated October 1960 (25 October 1960 per IIFL company summary) in Bombay (now Mumbai); operations commenced 1961 (ICRA rationale, Oct 2025) |
| Incorporation jurisdiction | Maharashtra, India (CIN: L24224MH1960PLC011856, per company letterheads in BSE filings) |
| Registered office | Thirumalai House, Plot No. 101-102, Road No. 29, Near Sion Hill Fort, Sion (East), Mumbai 400 022, Maharashtra, India |
| Principal operating office / works | No. 556, Vanagaram Road, Ambattur, Chennai 600 053, Tamil Nadu, India |
| Stock exchanges & tickers | BSE Ltd: scrip code 506685; National Stock Exchange of India: symbol ULTRAMAR |
| ISIN | INE405A01021 |
| CUSIP | Not applicable (no US listing) |
| Face value | ₹2 per share (split from ₹10 to ₹2 with a bonus issue, record date 18 October 2005) |
| Paid-up equity capital | ₹584 lakh as at 31 March 2026 (≈2.92 crore shares of ₹2 each) — FY2026 Directors' Report |
| Fiscal year end | 31 March |
| Employees (latest) | 1,256 permanent employees at end-FY2026 (624 in manufacturing; 632 in ITeS) — derived from gender-ratio disclosures in the FY2026 Directors' Report. Morningstar lists 1,072 (date of data not stated). 3-year trend: not publicly disclosed in sources reviewed |
| Statutory auditor | Sundaram & Srinivasan, Chartered Accountants, Chennai (FRN 004207S), appointed at the 63rd AGM on 25 July 2024 for a five-year term |
| Cost auditor | GSVK & Co., Cost Accountants (FY2027) |
| Internal auditor | M.S. Krishnaswamy & Co., Chartered Accountants |
| Secretarial auditor | R.M. Mimani & Associates LLP (five-year term from the 65th AGM) |
| Registrar & transfer agent | Cameo Corporate Services Ltd, Chennai |
| Market capitalisation (current) | ≈₹1,198 Cr at a share price of ₹410.10 (NSE close, 7 October 2026, per 5paisa) |
| Credit rating | [ICRA]A+ (Stable) long-term / [ICRA]A1+ short-term, reaffirmed 7 October 2025 |
| Website | https://ultramarinepigments.net |
| Promoter group | Sampath / Parthasarathy family; related listed company Thirumalai Chemicals Ltd (TCL) |
| Listing status vs. input | Input "Public company" — confirmed. Listed on BSE and NSE; small-cap. |
The entity profiled is Ultramarine & Pigments Limited (commonly abbreviated "UPL" in its own filings and by ICRA; not to be confused with UPL Ltd, the agrochemical company). The name and the company type supplied ("Public company") are both correct: this is an active, publicly listed Indian company. No name-matching substitution was required.
Ultramarine & Pigments Limited is a six-decade-old, promoter-controlled Indian chemicals company headquartered legally in Mumbai and operationally in Chennai. Its core identity is as one of India's largest producers of ultramarine blue (Pigment Blue 29), an inorganic pigment used across plastics, paints, coatings, cosmetics, inks, laundry whitening and building applications, with adjacent lines in ultramarine violet and pink, bismuth vanadate yellow and complex inorganic colour pigments (CICPs). By revenue, however, the company is primarily a contract-style sulphonation and surfactants supplier to large FMCG detergent and personal-care makers in South India, which generated roughly 63% of FY2026 revenue. A smaller but higher-margin IT-enabled services (ITeS) arm handles publishing/content services and healthcare billing. The company is conservatively financed (ICRA gearing ~0.1x), consistently dividend-paying, and is now embarking on its largest pigment capex in history — a ₹250 Cr greenfield plant in Tamil Nadu.
What the company does
Ultramarine & Pigments operates three reportable business segments as disclosed in its quarterly segment reporting: (1) Chemicals and Allied Products, which contains both inorganic pigments and surfactants/specialities; (2) IT-Enabled Services (ITeS), including BPO activity; and (3) Windmill (wind power generation), which is primarily captive. Morningstar's business description and the company's Q3 FY2026 filing confirm this three-segment structure.
Inorganic pigments. The company manufactures ultramarine blues (Pigment Blue 29), ultramarine violet (Pigment Violet 15), ultramarine pink (Pigment Red 259), bismuth vanadate (Pigment Yellow 184), and complex inorganic colour pigments/mixed metal oxides. The company's website emphasises "environmentally friendly" pigments usable across paints, plastics, inks, laundry and cosmetics. ICRA notes that high-grade ultramarine is used in plastics, paints, coatings, cosmetics, food and detergents, while lower grades go into whitewash and laundry applications. Pigments are made at Ambattur (Chennai) and Ranipet in Tamil Nadu by the parent, and at Naidupeta, Andhra Pradesh, by wholly owned subsidiary Ultramarine Specialty Chemicals Ltd (USCL), whose capacity reached 3,550 MTPA after an expansion completed in FY2026.
Surfactants and specialities. The company is a sulphonator producing linear alkyl benzene sulphonic acid (LABSA), alpha olefin sulphonate (AOS) and sodium lauryl ether sulphate (SLES), plus a growing basket of specialty/cosmetic-grade surfactants: medium chain triglyceride (MCT), benzalkonium chloride (BKC), cocamidopropyl betaine (CAPB), coco mono-ethanolamide (CMEA), coco diethanolamide (CDEA), cocamidopropylamine oxide (CAPAO), disodium laureth sulfosuccinate (DLESS) and lauryl amine oxide (LAO). It also sells detergent powder/liquid under the brand "OOB" (per ICRA). ICRA describes the company as among the key suppliers of surfactants to detergent manufacturers in South India, including large multinational FMCG players. Surfactants are produced at Ranipet (Tamil Nadu) and Naidupeta (Andhra Pradesh).
IT-enabled services. Started in 2000 under the leadership of current Vice Chairperson Indira Sundararajan, the ITeS division operates from Chennai and Ranipet and is commonly referenced as "Lapiz Digital Services" (third-party listing) alongside a customer/broadcast services unit. ICRA characterises it as specialising in content management, publishing and hospital billing services. In FY2026, ITeS income was ₹52 Cr with segment profit of ₹15 Cr.
Wind power. The company owns seven wind turbine generators at three Tamil Nadu locations with total capacity of 5 MW (FY2025: 4.3 MW), generating 80 lakh units in FY2026, all captively consumed at the Ranipet and Ambattur plants.
Business model and revenue model
| Revenue model component | Description | FY2026 indicative share of consolidated revenue |
|---|---|---|
| Product sales — surfactants & specialities | Volume-driven B2B supply to FMCG detergent and personal-care makers; pricing largely linked to feedstock (LAB, alpha olefins, fatty alcohols/ethoxylates) with limited value addition per ICRA | ≈63% (₹489 Cr of ₹775 Cr) |
| Product sales — inorganic pigments (parent) | B2B sales to plastics, coatings, inks, cosmetics, laundry and building-materials customers, domestic and export | ≈21% (₹164 Cr) |
| Product sales — inorganic pigments (subsidiary USCL) | Ultramarine and CICP output from Naidupeta | ≈10% (₹74 Cr, gross of any intercompany) |
| Services — ITeS/BPO | Fee-for-service publishing, content management, healthcare billing | ≈7% (₹52 Cr) |
| Captive power | Wind generation consumed internally; small reported segment revenue | <1% |
| Subscription / licensing | — | 0% |
Note: Segment figures are from the FY2026 Directors' Report; shares are derived and sum to slightly more than 100% because subsidiary revenue may include intercompany sales and divisional figures are not reconciled one-for-one with consolidated revenue in the report.
Value-chain position
The company sits in the mid-stream of two chemical chains. In surfactants it converts petrochemical and oleochemical intermediates (LAB, alpha olefins, fatty alcohol ethoxylates, coconut-derived amides) into anionic and amphoteric surfactants sold to consumer-goods formulators — a position with limited pricing power, as ICRA explicitly notes. In pigments it is closer to a specialty manufacturer, converting minerals and commodity inputs (kaolin/china clay, soda ash, sulphur, silica and reducing agents for ultramarine; bismuth and vanadium compounds for BiVaN; metal oxides for CICPs) into finished colorants. ITeS is a separate services value chain.
Customer types and end-markets
| End-market | Products | Customer type |
|---|---|---|
| Home care / laundry detergents | LABSA, AOS, SLES, OOB detergents, laundry-grade ultramarine | Large MNC and domestic FMCG players, regional detergent makers |
| Personal care & cosmetics | SLES, CAPB, amine oxides, DLESS, MCT, cosmetic-grade ultramarine | FMCG and cosmetics formulators |
| Plastics & masterbatch | Ultramarine blue/violet, BiVaN, CICPs | Compounders, masterbatch makers |
| Paints & coatings | Ultramarine, BiVaN, CICPs | Paint and coatings manufacturers |
| Printing inks | Ultramarine grades | Ink makers |
| Building materials / whitewash | Lower-grade ultramarine | Construction-chemicals and whitewash makers |
| Disinfection / institutional | BKC | Hygiene-product manufacturers |
| Publishing & healthcare (ITeS) | Content/publishing services; hospital billing | Global publishers; healthcare providers |
Company's own description vs. independent characterisation
The company describes itself on its website as "a leading manufacturer of inorganic pigments and surfactants" with a legacy of over 60 years, a client base across more than 50 countries, and a focus on quality, certifications (ISO 9001/14001/45001 per letterheads) and social responsibility. Its FY2026 Management Discussion attributes the year's growth to surfactants volumes and realisations, notes that export markets beyond the US offset tariff impacts, and flags rising input costs from West Asia disruptions.
Independent characterisation: UPL is best understood as a cash-generative, low-leverage surfactant converter with a niche global pigments franchise and a non-core but profitable services arm. Its brand identity rests on ultramarine, but its earnings mass increasingly rests on surfactants, which ICRA flags as low value-add. Margins have structurally reset from 23–25% (FY2019–FY2021) to 16–18% (FY2022–FY2026) as the surfactant mix rose. The balance sheet is dominated by a large equity investment in group company Thirumalai Chemicals, which introduces mark-to-market volatility and governance considerations unrelated to operating performance. The ₹250 Cr Manapparai greenfield is an explicit attempt to re-weight the portfolio back toward pigments.
Strategy
Stated strategic themes (FY2026 Annual Report and website, paraphrased)
-
Product-mix upgrade in surfactants — developing and adding high-value specialty chemicals to optimise revenue and margins.
-
Pigment capacity and diversification — completing USCL expansion (3,550 MTPA), building the Manapparai greenfield, and broadening beyond ultramarine into BiVaN and CICPs.
-
Export market diversification — offsetting US tariff impacts with volumes in other markets.
-
Green energy — wind capacity increased to 5 MW; green energy now 52% of total consumption (FY2025: 45%).
-
Operational excellence and governance — ERP-based controls, ERM framework, succession planning and leadership development.
-
Vision statement (website): global leadership and becoming the preferred choice while enhancing stakeholder value; quality, cost-effective and eco-friendly technologies; continual improvement; career development.
Strategic initiatives — last 24 months
| Date | Initiative | Scale / target | Status |
|---|---|---|---|
| Dec 2024 | SIPCOT Manapparai land (32.12 acres) | 99-year lease | Completed |
| FY2026 | USCL pigment expansion, Naidupeta | Capacity to 3,550 MTPA | Completed; CICP utilisation below plan |
| FY2026 | Wind capacity addition | 4.3 MW → 5 MW | Completed |
| FY2026 | New product commercialisation | 1 product + several grades | Completed; pipeline exists |
| 20 May 2026 | Greenfield inorganic pigments plant, Manapparai | ₹250 Cr; 2,500 MTPA; phased FY2028 and FY2029; funded by internal accruals + term loans | Approved; early stage |
| Dec 2025 | Strategic investment in TCL preferential issue | ₹45 Cr | Completed |
| Apr 2026 | Inter-corporate loan to TCL | ₹65 Cr, 3 years, 10% | Executed |
| Nov 2025 | New Labour Codes compliance | ₹1.71 Cr one-time cost | Completed |
Capital intensity of greenfield (derived): ₹250 Cr ÷ 2,500 MT = ₹10 lakh per tonne of capacity. The project equals ~32% of FY2026 consolidated revenue and ~21% of current market capitalisation.
Medium-term financial targets / guidance
The company does not publish quantified guidance, medium-term revenue or margin targets, and does not hold earnings calls or investor days identified in reviewed sources. Management's qualitative outlook (FY2026 MD&A): export growth supported by lower US tariffs; continuing risk from West Asia-driven input inflation, supply-chain instability, austerity measures and rising fuel costs.
Products & Services
Pricing models are not publicly disclosed for any product; the company sells B2B on negotiated contracts or spot terms. Launch years are not disclosed for individual grades unless stated.
5A. Inorganic Pigments (Chemicals & Allied Products segment)
| Product | Colour Index | Description & key capabilities | Target customers | Notes |
|---|---|---|---|---|
| Ultramarine Blue | Pigment Blue 29 | Sodium aluminosilicate-sulphur complex pigment; non-toxic, heat-stable, alkali-resistant; multiple grades from high-purity cosmetic/plastics grades to laundry/whitewash grades | Plastics, masterbatch, paints, coatings, inks, cosmetics, detergents/laundry, building materials | Flagship; ICRA identifies it as the dominant pigment revenue source and a concentration risk |
| Ultramarine Violet | Pigment Violet 15 | Violet analogue of ultramarine; used for reddish shading and cosmetics | Cosmetics, plastics, coatings | Niche |
| Ultramarine Pink | Pigment Red 259 | Pink ultramarine derivative | Cosmetics, specialty plastics | Niche |
| Bismuth Vanadate | Pigment Yellow 184 | High-chroma, heavy-metal-free yellow; substitute for lead chromate and cadmium yellows | Automotive/industrial coatings, plastics | Higher-value diversification product |
| Complex Inorganic Colour Pigments (CICPs) / mixed metal oxides | Various | High-temperature-calcined pigments with extreme weatherability and heat stability | Coil coatings, engineering plastics, ceramics, building materials | Produced at USCL's CICP plant, Naidupeta; utilisation below plan in FY2026 |
Capacity (ICRA, Oct 2025): 9,715 MTPA total pigment capacity (group). USCL capacity 3,550 MTPA post FY2026 expansion. Planned additional 2,500 MTPA at Manapparai (FY2028–FY2029).
5B. Surfactants (Chemicals & Allied Products segment)
| Product | Type | Description | Target customers |
|---|---|---|---|
| Linear Alkyl Benzene Sulphonic Acid (LABSA) | Anionic | Primary active in detergent powders, bars and liquids; first sulphonation product (1996, 16,000 MTPA initial) | Detergent manufacturers |
| Alpha Olefin Sulphonate (AOS) | Anionic | High-foaming, hard-water-tolerant surfactant | Liquid detergents, shampoos, hand wash |
| Sodium Lauryl Ether Sulphate (SLES) | Anionic | Mild, high-foaming surfactant for personal care and dishwash | Personal care, dishwash formulators |
Capacity (ICRA, Oct 2025): 62,000 MTPA surfactants. Ranipet reported at optimum utilisation in FY2026; Naidupeta utilisation improving.
5C. Specialty Chemicals (Chemicals & Allied Products segment)
| Product | Abbreviation | Function | End-use |
|---|---|---|---|
| Medium Chain Triglyceride | MCT | Emollient/carrier oil | Cosmetics, personal care |
| Benzalkonium Chloride | BKC | Cationic biocide/disinfectant | Hygiene, disinfectants |
| Cocamidopropyl Betaine | CAPB | Amphoteric co-surfactant, mildness booster | Shampoos, body wash |
| Coco Mono Ethanol Amide | CMEA | Foam booster/thickener | Shampoos, detergents |
| Coco Diethanolamide | CDEA | Foam stabiliser/thickener | Personal care, household |
| Cocamidopropylamine Oxide | CAPAO | Amphoteric co-surfactant | Dishwash, personal care |
| Disodium Laureth Sulfosuccinate | DLESS | Mild anionic surfactant | Baby care, sulphate-free formulations |
| Lauryl Amine Oxide | LAO | Foam booster, grease cutting | Dishwash, hard-surface cleaners |
FY2026 Directors' Report: one new product was commercialised and several new grades added; more are in the pipeline using existing infrastructure. Specific product names for FY2026 launches are not disclosed.
5D. Detergents (Chemicals & Allied Products segment)
| Brand | Product | Notes |
|---|---|---|
| OOB | Detergent powder and liquid | Brand named by ICRA; small scale; market share not disclosed |
5E. IT-Enabled Services (ITeS segment)
| Service line | Description | Target customers |
|---|---|---|
| Publishing & content management (reported as "Lapiz Digital Services" in third-party listings) | Digital publishing, typesetting/content conversion, content management | International publishers |
| Hospital/medical billing | Revenue-cycle services for healthcare providers | Healthcare providers (geography not disclosed) |
| Customer / broadcast services (BPO) | Customer-contact and related BPO services | — |
Delivery centres: Chennai and Ranipet. FY2026: 632 employees, 50% women. Management cited focus on service quality, process automation and business development.
5F. Windmill (Windmill segment)
| Asset | Capacity | FY2026 output | Use |
|---|---|---|---|
| 7 wind turbine generators, 3 Tamil Nadu sites | 5 MW (FY2025: 4.3 MW) | 80 lakh units (FY2025: 57 lakh) | 100% captive at Ranipet and Ambattur |
Financial Narrative
Source: Consolidated financials as compiled by Screener.in from annual reports (FY2022–FY2026), cross-checked against the FY2026 Directors' Report (revenue ₹774.77 Cr, PBT ₹104.67 Cr, PAT ₹80.77 Cr), ICRA rationale (FY2024–FY2025), and Business Standard/Capital Market result summaries. Screener rounds to whole crores.
Income statement (INR Cr)
Operating income (EBIT): derived as EBITDA less depreciation: FY2022 ₹72 Cr; FY2023 ₹85 Cr; FY2024 ₹73 Cr; FY2025 ₹95 Cr; FY2026 ₹99 Cr. Basic and diluted EPS are identical (no dilutive instruments; no ESOPs per FY2026 report).
Margins and growth (%)
CAGRs (derived): Revenue FY2022–FY2026: 12.1%. Net profit FY2022–FY2026: 8.7%. EPS FY2022–FY2026: 8.5%. Screener reports 5-year sales CAGR of 20% (FY2021 base of ₹308 Cr, before the surfactant step-up) and 5-year profit CAGR of 7%.
Commentary. FY2022 was the inflection year: revenue jumped 59% as surfactant volumes and feedstock-driven prices rose, but EBITDA margin collapsed from ~25% (FY2020–FY2021) to 17% because surfactants are pass-through, low-margin products. ICRA attributes the margin reset (23–25% in FY2019–FY2021 to 17–18% in FY2022–FY2025) to high raw material prices and the higher surfactant contribution. FY2024 was a pause year — revenue flat and PAT down 16% as depreciation rose with USCL's commissioning and interest costs rose on its term loan. FY2025 delivered 24% revenue growth on higher realisations and volumes (ICRA). FY2026 grew 11.5% (surfactants +14%) but margins slipped to 16.3% as Q4 input costs surged following West Asian geopolitical events; PBT rose only 5%. Depreciation has more than doubled since FY2022 (₹12 Cr to ₹27 Cr) reflecting the USCL build-out, which is still under-utilised.
Quarterly trajectory (INR Cr, consolidated)
Sources: Capital Market/Business Standard summaries (Q1FY26, Q2FY26, Q1FY27), company Q3/Q4 filings via ScanX/Trendlyne. Q2FY26 and Q1FY27 EPS derived from PAT ÷ 2.92 crore shares. Q3FY26 PAT includes a net exceptional gain of ₹4.26 Cr (NHAI land compensation ₹5.77 Cr + ₹0.20 Cr interest, less ₹1.71 Cr labour-code charge). Q1FY27 OPM was 18.95% vs 17.24% in Q1FY26; PBDT rose 51% to ₹49.72 Cr.
Q1 FY2027 inflection: Revenue up 30% YoY and PAT up 56% — the strongest quarter in company history, coming immediately after the weakest quarter of FY2026. Drivers were not explained in reviewed summaries; plausible contributors (not confirmed by management) include price pass-through of Q4 input cost spikes, USCL ramp-up and export recovery after US tariff reductions referenced in the FY2026 MD&A. TTM PAT (Q2FY26–Q1FY27) = ₹92.2 Cr; TTM EPS ≈ ₹31.6.
Balance sheet (INR Cr, consolidated, 31 March)
Net debt (derived, FY2025): ₹94 Cr borrowings (Screener basis) − ₹74.23 Cr cash & liquid investments (ICRA) ≈ ₹20 Cr; on ICRA's external term loan basis (₹85.79 Cr) ≈ ₹11.6 Cr. Excluding strategic equity investments, the company is near net-debt-neutral.
The investment line is the dominant balance-sheet swing factor. The ₹376–551 Cr investment book consists principally of the company's equity stake in Thirumalai Chemicals (carried at fair value through OCI) plus mutual fund treasury holdings. Reserves fell from ₹967 Cr to ₹864 Cr in FY2026 despite ₹81 Cr of profit — consistent with a decline in TCL's share price. In Q1 FY2026 alone the company booked an unrealised OCI gain of ₹551 Cr on investments (FilingReader summary of the filing), illustrating the magnitude of this exposure relative to operating earnings. Book value is therefore heavily influenced by a single related-party equity holding.
Cash flow (INR Cr)
Capex derived as CFO minus Screener FCF. Dividends paid derived as prior-year DPS × 2.92 crore shares. No buybacks have been authorised or executed in the period.
Commentary. Cash conversion has improved markedly: CFO/EBITDA rose from 56% in FY2022 (working-capital build during the surfactant price spike) to 118% in FY2026 as working-capital days fell from 82 to 43. FY2026 FCF of ₹62 Cr was the highest in the period. The large FY2026 investing outflow (₹148 Cr) reflects capex plus the ₹45 Cr subscription to TCL's preferential issue and treasury movements. FY2027 investing outflows will rise further with the ₹65 Cr loan to TCL (April 2026) and the start of the ₹250 Cr Manapparai project.
Ratio analysis
Derived ratios use Screener-rounded inputs. ROE FY2022 uses FY2021 equity of ~₹461 Cr. ICRA's own calculations: interest coverage 13.1x (FY2024), 16.4x (FY2025), 19.0x (Q1 FY2026); total debt/OPBDITA 0.8x (FY2024 and FY2025); TOL/TNW 0.2x. Current ratio and ROIC: not publicly disclosed in reviewed sources. Net debt/EBITDA: ≈0.2x for FY2025 (derived); other years not verifiable.
Commentary. Return ratios are structurally depressed (ROE 7–9%) not because operations are weak but because roughly a third to half of equity is tied up in the TCL stake and treasury investments that generate little P&L return. On an operating basis (EBIT ≈ ₹99 Cr against net fixed assets plus working capital of very roughly ₹500 Cr), operating returns are meaningfully higher than headline ROE — though a precise operating ROIC cannot be verified. Leverage is minimal and interest coverage strong; ICRA's downgrade trigger is TD/OPBDITA above 1.8x on a sustained basis. The working-capital cycle improved materially in FY2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Incorporated | Status | Notes |
|---|---|---|---|---|
Ultramarine & Pigments Ltd | Listed parent | Oct 1960, Mumbai | Operating | Pigments (Ambattur, Ranipet), surfactants (Ranipet, Naidupeta), ITeS, wind |
Ultramarine Specialty Chemicals Ltd (USCL) | 100% subsidiary; "material subsidiary" under SEBI LODR | 9 Dec 2019, Chennai | Operating since Aug 2022 | Naidupeta, AP pigments incl. CICP plant; auditor Brahmayya & Co.; recommended 7.5% preference dividend (Jul 2025) |
Ultramarine Fine Chemicals Ltd | 100% subsidiary | FY2022/FY2023 | Not yet commenced operations | Purpose not detailed in reviewed filings |
Segment Overview
| Segment | Contents | Key products |
|---|---|---|
Chemicals and Allied Products | Inorganic pigments (parent + USCL) and surfactants/specialities and detergents | Ultramarine blue/violet/pink, BiVaN, CICPs; LABSA, AOS, SLES, specialty surfactants, OOB detergent |
IT-Enabled Services | ITeS and BPO | Publishing/content management, hospital billing, customer services |
Windmill | Wind turbine generators | Captive power (5 MW) |
Revenue by Segment
| Division (INR Cr, FY2026 Directors' Report) | FY2025 | FY2026 |
|---|---|---|
Surfactants & Specialities revenue (INR Cr) | 430 | 489 |
Inorganic Pigments — parent revenue (INR Cr) | 175 | 164 |
Inorganic Pigments — USCL subsidiary revenue (INR Cr) | 54 | 74 |
ITeS income (INR Cr) | 45 | 52 |
Consolidated revenue from operations (INR Cr) | 695 | 775 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Revenue
| Division | FY2026 YoY growth | FY2026 % of consolidated revenue (derived) | FY2025 % of consolidated revenue (derived) |
|---|---|---|---|
Surfactants & Specialities | +13.7% | 63.1% | 61.9% |
Pigments — parent | −6.3% | 21.2% | 25.2% |
Pigments — USCL | +37% (company-stated) | 9.5% | 7.8% |
Pigments — combined (gross) | +3.9% (238 vs 229) | 30.7% | 32.9% |
ITeS | +15.6% | 6.7% | 6.5% |
Results by Segment
| Metric (INR Cr) | FY2025 | FY2026 |
|---|---|---|
ITeS segment profit (INR Cr) | 0 | 15 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 490 | 557 | 561 | 695 | 775 |
Operating expenses (INR Cr) | 406 | 455 | 466 | 576 | 649 |
EBITDA excl. other income (INR Cr) | 84 | 102 | 95 | 119 | 126 |
Other income (INR Cr) | 9 | 11 | 10 | 12 | 13 |
Depreciation (INR Cr) | 12 | 17 | 22 | 24 | 27 |
Interest (INR Cr) | 4 | 5 | 7 | 7 | 7 |
Profit before tax (INR Cr) | 78 | 91 | 76 | 100 | 105 |
Net profit (INR Cr) | 58 | 69 | 58 | 75 | 81 |
EPS basic/diluted (INR) | 19.97 | 23.70 | 19.73 | 25.70 | 27.66 |
Dividend per share (INR) | 5 | 5 | 5 | 6 | 6 |
Effective tax rate (%) | 25 | 24 | 24 | 25 | 23 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin (%) | 17.1 | 18.3 | 16.9 | 17.1 | 16.3 |
EBIT margin (%) | 14.7 | 15.3 | 13.0 | 13.7 | 12.8 |
PBT margin (%) | 15.9 | 16.3 | 13.5 | 14.4 | 13.5 |
Net margin (%) | 11.8 | 12.4 | 10.3 | 10.8 | 10.4 |
Revenue growth YoY (%) | 59.1 | 13.7 | 0.7 | 23.9 | 11.5 |
Net profit growth YoY (%) | 3.6 | 19.0 | -15.9 | 29.3 | 8.0 |
Dividend payout (%) | 25 | 21 | 25 | 23 | 22 |
Income Statement and Per-Share Data (Quarterly)
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 184.38 | 196.07 | 195.60 | 198.71 | 239.96 |
Profit before tax (INR Cr) | 26.55 | 25.81 | 33.93 | 18.38 | 42.38 |
Net profit (INR Cr) | 20.19 | 19.36 | 27.09 | 14.15 | 31.59 |
EPS (INR) | 6.91 | 6.63 | 9.28 | 4.85 | 10.82 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 995 | 881 | 1,076 | 1,173 | 1,094 |
Net fixed assets (INR Cr) | 152 | 238 | 281 | 334 | 373 |
Capital work in progress (INR Cr) | 69 | 29 | 30 | 26 | 30 |
Investments (INR Cr) | 551 | 366 | 492 | 513 | 376 |
Other assets incl. working capital and cash (INR Cr) | 222 | 248 | 274 | 299 | 315 |
Borrowings total (INR Cr) | 53 | 75 | 79 | 94 | 86 |
Other liabilities (INR Cr) | 82 | 70 | 97 | 106 | 138 |
Shareholders' equity (INR Cr) | 860 | 736 | 900 | 973 | 870 |
Book value per share (INR) | 294 | 252 | 308 | 333 | 298 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 29 | 62 | 78 | 90 | 128 |
Capex derived (INR Cr) | 69 | 61 | 63 | 53 | 66 |
Free cash flow (INR Cr) | -40 | 1 | 15 | 37 | 62 |
Investing cash flow total (INR Cr) | -63 | -55 | -51 | -42 | -148 |
Financing cash flow (INR Cr) | -7 | -2 | -18 | -33 | -31 |
Dividends paid approx derived (INR Cr) | 15 | 15 | 15 | 15 | 18 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO to EBITDA (%) | 56 | 81 | 100 | 94 | 118 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | 8.8 | 8.6 | 7.1 | 8.0 | 8.8 |
ROA on closing assets (%) | 5.8 | 7.8 | 5.4 | 6.4 | 7.4 |
ROCE per Screener (%) | 11 | 11 | 9 | 10 | 11 |
Debt to equity (x) | 0.06 | 0.10 | 0.09 | 0.10 | 0.10 |
Interest coverage EBITDA to interest (x) | 21.0 | 20.4 | 13.6 | 17.0 | 18.0 |
Asset turnover (x) | 0.49 | 0.63 | 0.52 | 0.59 | 0.71 |
Debtor days | 29 | 29 | 38 | 42 | 38 |
Inventory days | 93 | 113 | 109 | 83 | 88 |
Payable days | 52 | 53 | 69 | 49 | 69 |
Cash conversion cycle (days) | 71 | 89 | 79 | 76 | 56 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Consolidated export revenue (INR Cr) | 211 | 226 |
Consolidated domestic revenue derived (INR Cr) | 484 | 549 |
Standalone export revenue (INR Cr) | 184 | 176 |
Standalone domestic revenue derived (INR Cr) | 467 | 531 |
Consolidated export share (%) | 30.4 | 29.2 |
Geography Overview
| Geography | FY2026 YoY growth |
|---|---|
Consolidated exports | +7.1% |
Consolidated domestic (derived) | +13.4% |
Standalone exports | −4.3% |
Subsidiary-driven exports (derived: consolidated minus standalone) | ₹27 Cr → ₹50 Cr (+85%) |
Markets
| Market | Disclosure | Source |
|---|---|---|
United States | 5–8% of total revenues; tariff impact expected to be limited | ICRA, Oct 2025 |
South Korea, Europe | Named export destinations | ICRA, Oct 2025 |
India — South | Core surfactant market; supplies MNC FMCG players | ICRA |
Global reach | Clients in over 50 countries | Company website |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Last price | ₹410.10 | NSE close, 7 Oct 2026 (5paisa) |
Market capitalisation | ≈₹1,198 Cr | 5paisa, 8 Oct 2026 |
52-week high / low | ₹490 / ₹364 (low on 19 Jun 2026) | 5paisa; Business Standard |
All-time high | ₹613.95 (21 Jul 2025) | Business Standard |
50-DMA / 200-DMA | ₹412.80 / ₹415.70 | 5paisa |
Average daily volume (sample day) | ~28,000 shares (7 Oct 2026) | 5paisa — thinly traded |
Return period | Return | — |
1 month | −6.1% (5paisa, Oct 2026) | — |
3 months | +6.6% (5paisa) | — |
6 months | +3.3% (5paisa) | — |
1 year | −8.9% (5paisa) | — |
3-year CAGR | ~2% (Screener, as of late Jul 2026) | — |
5-year CAGR | ~1% (Screener, as of late Jul 2026) | — |
10-year CAGR | ~10% (Screener, as of late Jul 2026) | — |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
P/E (TTM) | ~13.0x | ₹410 ÷ TTM EPS ₹31.6 (Q2 FY26–Q1 FY27) |
P/E (FY2026) | ~14.8x | ₹410 ÷ ₹27.66 |
P/B | ~1.38x | ₹410 ÷ FY2026 BVPS ₹298 (5paisa shows 1.3x) |
EV/Sales (FY2026) | ~1.6x | EV ≈ ₹1,198 Cr mcap + ₹86 Cr debt − ~₹53 Cr cash (aggregator) ≈ ₹1,231 Cr |
EV/EBITDA (FY2026) | ~9.8x | ₹1,231 Cr ÷ ₹126 Cr |
EV/EBITDA adjusted for investments | ~6.8x | Further deducting ~₹376 Cr investment book (TCL stake + treasury) — illustrative |
Dividend yield | ~1.5% | ₹6 ÷ ₹410 |
Per-Share Data
| Metric | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
Dividend per share (INR) | 4.5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
Credit Ratings
| Agency | Instrument | Rating | Outlook | Date |
|---|---|---|---|---|
ICRA | Long-term fund-based cash credit (₹1.00 Cr) | [ICRA]A+ | Stable | 7 Oct 2025 |
ICRA | Long-term term loan (₹16.60 Cr) | [ICRA]A+ | Stable | 7 Oct 2025 |
ICRA | LT/ST fund/non-fund based (₹5.00 Cr) | [ICRA]A+ / [ICRA]A1+ | Stable | 7 Oct 2025 |
ICRA | Short-term non-fund based (₹15.00 Cr) | [ICRA]A1+ | — | 7 Oct 2025 |
Moody's / S&P / Fitch | — | Not rated | — | — |
Capital Markets
| Item | Detail |
|---|---|
External term loan outstanding (31 Mar 2025) | ₹85.79 Cr (ICRA) |
Due within FY2026 | ~₹18.87 Cr |
Rated term loan | ₹16.60 Cr; issued Dec 2019; 8.4%; final maturity June 2028 |
Working-capital limits | Largely unutilised (ICRA) |
Prospective | Manapparai greenfield to be part-funded by new term loans (amount not disclosed) |
Analyst Conclusions
Management guidance
No quantitative guidance is issued. Qualitative outlook (FY2026 MD&A): export growth supported by lower US tariffs; continued pressure from West Asia-linked input costs, supply-chain instability, austerity and fuel costs; continued focus on specialty surfactants and new pigment products; greenfield capacity in FY2028–FY2029.
Consensus expectations
None available (no sell-side coverage). Run-rate observation: Q1 FY2027 annualised revenue ≈ ₹960 Cr and PAT ≈ ₹126 Cr, but a single quarter following a weak Q4 should not be extrapolated.
Bull case
-
Earnings inflection is underway. Q1 FY2027 revenue +30% and PAT +56% with OPM expanding to 18.95% suggests pricing power returned after Q4's cost spike and that USCL capacity is beginning to contribute; even modest continuation implies FY2027 PAT well above FY2026's ₹81 Cr.
-
Pigment re-weighting improves quality of earnings. USCL (3,550 MTPA) plus the 2,500 MTPA Manapparai plant would lift pigments' share from ~31% of revenue, structurally raising group margins toward historical 20%+ levels — the precise mix effect ICRA identified as the cause of the margin decline.
-
Valuation is undemanding with asset backing. At ~13x TTM P/E and ~1.4x book, with ~₹376 Cr of investments (≈31% of market cap) and A+ credit, downside is cushioned while the company funds growth largely internally.
Bear case
-
Capital allocation is drifting toward the promoter group. In five months UPL deployed ~₹110 Cr into TCL (₹45 Cr equity + ₹65 Cr unsecured loan) — more than FY2026 PAT — while TCL reported a wider FY2026 consolidated loss; minority shareholders bear credit and equity risk on a related party.
-
Commodity-like core and execution risk. Surfactants (63% of revenue) are low value-add per ICRA; USCL's CICP plant has already disappointed on utilisation; a ₹250 Cr greenfield adds depreciation and debt ahead of uncertain demand, risking a repeat of FY2024's flat-earnings year.
-
Structural return problem. ROE has not exceeded ~9% in five years; volatile OCI swings on the TCL stake drive book value; thin liquidity, ~2% institutional ownership and no guidance limit rerating catalysts.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| Q2 FY2027 results | ~Nov 2026 | Sustainability of Q1 margin (18.95%) and revenue (~₹240 Cr) |
| SAST disclosure details | Immediate | Whether TCL bought from market or intra-group; implications for promoter stake |
| TCL loan servicing | Ongoing | Interest receipts at 10%; any extension or increase |
| Manapparai greenfield | FY2027 | Debt raised, ground-breaking, cost discipline |
| USCL utilisation | Quarterly | CICP plant ramp; subsidiary PAT (third-party summary of Q1 FY2027 filing indicates USCL quarterly PAT ~₹3.5 Cr on ~₹24.8 Cr income) |
| Input costs | Ongoing | LAB/alpha olefin prices; West Asia developments |
| US tariff regime | Ongoing | Pigment export volumes |
| ICRA surveillance | ~Oct 2026 | Rating action in light of capex and related-party loans |
| Q4 FY2027 / dividend | May 2027 | Whether dividend rises above ₹6 |
Analyst verdict
Ultramarine & Pigments is a well-run, conservatively financed small-cap whose operating franchise is better than its headline returns suggest and whose capital allocation is less disciplined than its balance sheet suggests. The operating core — a 65-year ultramarine franchise, an entrenched surfactant supply position with multinational FMCG customers, and a quietly profitable ITeS arm — has compounded revenue at ~12% over four years, generated rising free cash flow (₹62 Cr in FY2026), and maintained EBITDA margins well above larger Indian peers such as Galaxy Surfactants and Sudarshan Chemical. Q1 FY2027's record quarter demonstrates that pricing can recover quickly after input shocks.
The investment case, however, is clouded by three issues. First, the business mix has drifted toward low-value surfactants, compressing margins from ~25% to ~16%; the Manapparai greenfield is the right strategic response but carries execution risk evidenced by USCL's under-utilised CICP plant. Second, nearly a third of the market capitalisation and a large share of book value sit in a related-party equity stake whose price swings dwarf operating profit, depressing ROE to 7–9% and making reported net worth volatile. Third, and most importantly, the ₹110 Cr deployed into Thirumalai Chemicals between December 2025 and April 2026 — on top of the existing cross-holding, and followed by unexplained SAST movements in October 2026 — signals that surplus cash may be steered toward group needs rather than minority-shareholder returns.
At roughly 13x trailing earnings, ~1.4x book, ~10x EV/EBITDA (lower if investments are netted) and an A+ credit, the valuation already discounts much of this. The stock is best characterised as value with a governance discount.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Designation | Category | Tenure / background |
|---|---|---|---|
R. Sampath | Chairman | Non-Executive, Promoter | Joined 1970 as Project Engineer; MD 1990; CMD 1998–Mar 2016; Non-Executive Chairman since. B.Sc. Chemistry (Univ. of Bombay); Chemical Engineering degree, Washington State University |
Indira Sundararajan | Vice Chairperson | Executive/Promoter group (designation per website) | B.Sc.(Tech), gold medallist, UDCT (now ICT) Mumbai; founded ITeS division 2000; WTD 2012; VC & MD from 2015 |
Tara Parthasarathy (DIN 07121058) | Managing Director | Executive, Promoter group | B.Tech (Anna University); Master of Environmental Management (Yale); JMD 2015; heads sulphonation; signed FY2026 Board's Report; re-appointed by rotation at 65th AGM (22 Jul 2026) |
V. Bharathram | Managing Director | Executive, Promoter group | Computer Science graduate, MBA; MD since 2019; oversees pigments & surfactants; CSR Committee member |
R. Senthil Kumar (DIN 07506927) | Whole-time Director | Executive | Former GM – Operations; WTD since 1 Aug 2016; runs Ambattur and Ranipet plants |
C.R. Chandra Bob | Independent Director | Independent | CSR Committee Chairman |
Harsh R. Gandhi | Independent Director | Independent | — |
B.K. Sethuram(an) | Independent Director | Independent | — |
Hemalatha Mohan | Independent Director | Independent | CSR Committee member |
R. Ravi Shankar | Independent Director | Independent | — |
Governance Overview
| Attribute | Detail |
|---|---|
Board size | 10 |
Independent directors | 5 (50%) |
Women directors | 3 (Indira Sundararajan, Tara Parthasarathy, Hemalatha Mohan) |
Chair/CEO separation | Yes — Non-Executive Chairman; executive leadership shared by two MDs and a Vice Chairperson |
Lead Independent Director | Yes (named role; individual not identified in excerpt) |
Board meetings FY2026 | Six |
Committees | Audit; Nomination & Remuneration; CSR; Stakeholders Relationship; Risk Management |
Risk Management Committee meetings FY2026 | 25 Sep 2025; 13 Mar 2026 |
Independent Directors' meetings FY2026 | 19 Sep 2025; 18 Mar 2026 |
Board & Management Changes
| Date | Change |
|---|---|
22 Jul 2026 | Tara Parthasarathy re-appointed (retirement by rotation) |
22 Jul 2026 | R.M. Mimani & Associates LLP appointed Secretarial Auditor for five years |
25 Jul 2024 | Sundaram & Srinivasan appointed statutory auditors |
Major Shareholders
| Holder category (30 Jun 2026, per 5paisa) | % |
|---|---|
Promoter & promoter group | 40.49 |
Foreign institutional investors | 1.42 |
Other institutions (DIIs) | 0.64 |
Public (retail & others) | 57.45 |
Major Shareholders by Holder
| Holder | Stake | Source / date |
|---|---|---|
Thirumalai Chemicals Ltd (promoter group) | 14.38% | MarketsMojo, Mar 2026 shareholding |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | HQ | Positioning vs UPL |
|---|---|---|---|
Ultramarine pigments (global) | Holliday Pigments (carved out of Venator; acquired by Mutares in 2026) | Comines, France | Self-described #2 globally in technical-grade ultramarine; ~EUR 30m revenue, 115 employees (Mutares) |
Ultramarine / inorganic pigments | Vibrantz Technologies (owner of Nubiola ultramarine and CICP lines; formerly Ferro) | USA/Spain | — |
Ultramarine pigments | Chinese ultramarine producers (multiple) | China | Low-cost competition; ICRA cites competition from global players |
Inorganic & organic pigments (India/global) | Sudarshan Chemical Industries (incl. acquired Heubach business) | Pune, India | Much larger diversified pigment major; FY2026 revenue ₹9,787 Cr |
Organic pigments (India) | Asahi Songwon Colors | Ahmedabad, India | Phthalocyanine blue leader; adjacent rather than direct |
Pigments/colorants (India) | Kiri Industries, Bodal Chemicals, Poddar Pigments | India | Listed peers in dyes & pigments classification; limited direct overlap |
BiVaN & CICPs | Sun Chemical/DIC (ex-BASF pigments), Shepherd Color, Heubach (Sudarshan) | Global | Technology leaders in high-performance inorganic pigments |
Surfactants (India) | Galaxy Surfactants | Navi Mumbai, India | Largest Indian oleochemical surfactant maker; FY2026 revenue ₹5,248 Cr |
Surfactants (India) | Aarti Surfactants | India | — |
Surfactants (global/India) | Clariant, BASF, Croda, Stepan | Global | Specialty surfactant leaders |
LABSA sulphonation | Numerous regional and unorganised sulphonators; captive sulphonation at FMCG majors | India | Price-driven competition (ICRA: low value addition, limited pricing flexibility) |
ITeS publishing | Straive (ex-SPi Global), Newgen KnowledgeWorks, Integra, TNQ Technologies, Aptara | India (Chennai cluster) | Larger, specialised publishing-services firms |
Peer Comparison FY2026
| Metric | UPL | Galaxy Surfactants | Sudarshan Chemical |
|---|---|---|---|
Revenue from operations (INR Cr) | 775 | 5,248 | 9,787 |
Revenue growth YoY (%) | 11.5 | 7.1 | 192.5 |
Operating profit EBITDA (INR Cr) | 126 | 497 | 669 |
EBITDA margin (%) | 16.3 | 9.5 | 6.8 |
Net profit (INR Cr) | 81 | 267 | 41 |
Net margin (%) | 10.4 | 5.1 | 0.4 |
Recent Developments
--



